BioMarin Pharmaceuticals Inc
€45.01
EUR
Last updated on --.
24h volume2.34M
24h highest45.8413 EUR
24h lowest44.8868 EUR
24h Price movement-1.00%
BMRN recent prices
24 Hours
-1.00%-€0.45575
30 days
-0.76%-€0.34912
60 days
-3.46%-€1.631
90 days
-14.31%-€7.599
Key data
Previous close45.4715 EUR
Market cap8.34B EUR
Volume2.34M
P/E ratio36.100000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)1.1953 EUR
Net income (FY)231.09M EUR
Revenue (FY)2.79B EUR
Last report dateMay 5, 2026
About BioMarin Pharmaceuticals Inc
HeadquartersNOVATO
Employees (FY)3.22K
Revenue per employee (FY)865.59K EUR
Net income per employee (FY)71.75K EUR
Listed onNasdaq
BMRN conversion tables
 |  |
|---|---|
| 0.5 BMRN | 22.5 EUR |
| 1 BMRN | 45.01 EUR |
| 5 BMRN | 225.07 EUR |
| 10 BMRN | 450.15 EUR |
| |
|---|---|
| 0.5 EUR | 0.011107 BMRN |
| 1 EUR | 0.022214 BMRN |
| 5 EUR | 0.11107 BMRN |
| 10 EUR | 0.22214 BMRN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BMRN is trading at €45.01, -1.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BMRN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BMRN is currently trading at €45.01, -1.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BMRN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BMRN's P/E ratio is currently 36.100000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BMRN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BMRN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
BioMarin Pharmaceuticals Inc's market cap is currently 8.34B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.34M
24h highest45.8413 EUR
24h lowest44.8868 EUR
24h Price movement-1.00%
Start trade with BMRN Perpetual
Sign up to trade